Tianjin Medical University Second Hospital

This study tests if a combination of three treatments—a targeted procedure to block blood flow to the tumor, an immunotherapy drug, and a targeted therapy pill—can shrink advanced kidney cancer before surgery. About 40 adults with certain stages of kidney cancer will receive this…

This study looks at whether a urine test for tumor DNA can help doctors decide how long to give immunotherapy to people with a severe, hard-to-treat type of bladder cancer. About 53 adults with very-high-risk non-muscle-invasive bladder cancer that cannot be fully removed by surg…

This study looks at whether removing nearby lymph nodes during standard surgery for a rare kidney and ureter cancer (upper tract urothelial carcinoma) helps prevent the cancer from coming back. About 150 adults with high-risk cancer will be randomly assigned to get either the sta…

This study tests two drugs, SKB264 and KL-A167, together in people with aggressive or neuroendocrine prostate cancer that has stopped responding to hormone therapy. The goal is to see if the combination can shrink tumors or slow the disease. About 28 adults who have already tried…

This study tests a combination of two drugs (tislelizumab and nab-paclitaxel) to treat a type of kidney cancer called renal pelvic cancer. The goal is to control the disease while saving the kidney, avoiding the need for full kidney removal. About 35 adults with early-stage cance…

This study is testing whether a combination of two newer drugs can shrink tumors before surgery for people with a high-risk type of cancer in the kidney or ureter that tests positive for a protein called HER2. The goal is to see if this pre-surgery treatment makes the cancer easi…

This study is testing whether a simple urine test can detect leftover cancer after initial surgery for high-risk bladder cancer. Currently, many patients need a second surgery to check for remaining tumor, but this procedure has risks and costs. The study will enroll 60 adults to…

This study is testing whether a urine DNA test can help decide when patients with high-risk bladder cancer need a cystoscopy (a camera exam inside the bladder). The goal is to safely reduce the number of uncomfortable and invasive cystoscopies without missing cancer recurrences. …

This study is testing whether a simple blood or urine test (called a liquid biopsy) can help find, monitor, and predict the return of urothelial carcinoma, a type of bladder cancer. Researchers will compare these test results with standard tissue biopsies in 300 people who have o…

This study looks at whether a urine test that detects tumor DNA can help doctors decide which bladder cancer patients truly need a second surgery. About 196 adults with non-muscle-invasive bladder cancer will be randomly assigned to have their repeat surgery decision guided by th…